4.810USD+2.34%Mkt Cap: 625.22M $P/E: —2d ago
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lig…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap625.22M $
Enterprise Value370.18M $
Revenue (TTM)206.71M $
Gross Profit104.46M $
Net Income (TTM)-66.54M $
Revenue/Share1.609 USD
Last Price4.810 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees682
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)66.57
PEG—
EV/EBITDA-9.31
EV/Revenue1.79
P/S2.93
P/B1.88
EPS (TTM)-0.62
EPS (Forward)0.07
52W Range
3.28053% of range6.180
52W High6.180 USD
52W Low3.280 USD
Profitability
Gross Margin51.84%
Oper. Margin-29.50%
EBITDA Margin-19.23%
Profit Margin-33.02%
ROE-19.47%
ROA-14.42%
Growth
Revenue Growth5.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.69M $
CapEx (TTM)4.19M $
FCF Margin4.50%
FCF Yield1.49%
Net Debt-235.54M $
Net Debt/EBITDA5.92
Balance Sheet
Debt/Equity0.07
Current Ratio4.48
Quick Ratio3.71
Book Value/Sh2.477 USD
Cash/Share2.016 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.563 USD
Upside (mean)+15.6%
Target Range4.750 USD – 7.500 USD
$4.750+15.6% to mean$7.500
# Analysts4
Ownership
Shares Out.129.98M
Float103.08M
Insiders8.36%
Institutions63.13%
Short Interest
Short Ratio6.1d
Short % Float4.76%
Short % Out.3.77%
Shares Short4.90M
Short (prev mo.)3.51M
Technical
SMA 504.417 (+8.9%)
SMA 2004.607 (+4.4%)
Beta1.17
S&P 52W Chg18.16%
Avg Vol (30d)796.35K
Avg Vol (10d)885.07K
Technical Indicators
RSI (14)57.9
MACD0.0888
MACD Signal0.0512
MACD Hist.+0.0375
BB Upper4.938 USD
BB Middle4.484 USD
BB Lower4.029 USD
BB Width20.26%
ATR (14)0.2158 USD
Vol Ratio (20d)1.11x